Determining Individualized Cancer Therapy in Pancreatic Cancer

Part of paid clinical trials in Milwaukee, Wisconsin.

Sponsor
Medical College of Wisconsin
Study ID
NCT05914987
Status
Recruiting
Apply to this trial

Conditions

  • Pancreatic Neoplasms

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Targeted Therapy — OTHER
    Approved interventions based on the subject's genomic profile will be provided to investigators for consideration for anti-tumor therapy.

Study Details

This is a non-therapeutic exploratory observational precision oncology study designed to collect and analyze data that demonstrate the clinical efficacy and tolerability of personalized treatments based on molecular tumor profiling assessments (i.e., matched therapy) in adult pancreatic cancer patients. Patient medical records, obtained both retrospectively and prospectively, will be examined for results of molecular profiling obtained through standard of care testing to help understand how well molecular testing might predicts response to therapy. Patient demographic and outcome parameters to be evaluated include, but are not limited to, tumor response, time to treatment failure, patient survival, and toxicity.

Key Dates

Start date
Dec 4, 2023
Status verified
Apr 2026
Primary completion
Aug 1, 2028
Completion
Aug 1, 2033

Study Design

Enrollment
1,000 participants (estimated)

Primary Outcome Measure

Number of Subjects Receiving Targeted Therapy [ Time Frame: 5 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Froedtert Hospital and the Medical College of WisconsinMilwaukeeWisconsin53226
Mandana Kamgar, MD
[email protected]
414-805-8900

Find similar trials in Milwaukee, WI

By research site
Froedtert Hospital and the Medical College of Wisconsin· Milwaukee, WI

Related Studies